Duodenal cancer is considered to be a small intestinal carcinoma in terms of
clinicopathology. In Japan, there are no established treatment guidelines based on sufficient …

Small bowel cancers account for 3% of all gastrointestinal malignancies and small bowel
adenocarcinomas represent a third of all small bowel cancers. Rarity of small bowel …

Small bowel adenocarcinoma (SBA) is a rare malignancy of the gastrointestinal tract that
has increased in incidence across recent years. Often diagnosed at an advanced stage …

Small bowel adenocarcinoma (SBA) is a rare tumour. We conducted a prospective cohort to
describe the prevalence, survival and prognostic factors in unselected SBA patients. The …

Background: Small bowel adenocarcinoma (SBA) is a rare malignancy that accounts for 1–
2% of gastrointestinal tumours. We investigated the clinical characteristics, outcomes, and …

Small bowel adenocarcinoma (SBA) is a rare malignancy, with a rising incidence in recent
decades, and accounts for roughly 40% of all cancers of the small bowel. The majority of …

Small bowel adenocarcinoma (SBA) is a rare cancer, but there is a growing impetus to
perform multicenter or collaborative studies to answer key questions in patient management …

Periampullary cancers include pancreatic, ampullary, biliary and duodenal cancers. At
presentation, the majority of periampullary tumours have grown to involve the pancreas, bile …

Opinion statement Small bower cancer is a rare disease, despite its incidence is increasing
in the last decade. Both benign and malignant tumors can arise from the small intestine. The …

Background Several studies have suggested that chemotherapy prolonged survival in
patients with metastatic or recurrent small bowel adenocarcinoma (SBA); however, there is …